FLXS
Flexsteel Industries, Inc.
FLXS has the edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
FLXS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
FLXS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
FLXS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $57.95 | -23% |
| Fair | 13x | $78.63 | +4.7% |
| Current | 13x | $75.13 | — |
| Forward | 14x | $75.13 | — |
| Expensive | 22x | $130 | +72% |
Historical ranges are pointers, not guarantees.
FLXS's PE is in its fair range at 13x. On analysts' estimates for next year's earnings, today's price would be 14x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
FLXS Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for FLXS, with profitability improving.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
FLXS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.54 | -7.7% |
| Q3 2026 | $6.00 | +46% |
| Q2 2026 | $6.07 | +71% |
| Q1 2026 | $5.52 | +117% |
| Q4 2025 | $3.67 | +2.5% |
| Q3 2025 | $4.11 | +62% |
| Q2 2025 | $3.54 | +83% |
| Q1 2025 | $2.54 | -14% |
| Q4 2024 | $3.58 | +23% |
FLXS has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
FLXS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $114M | +3.2% |
| Q2 2026 | $115.4M | +0.7% |
| Q1 2026 | $115.1M | +1% |
| Q4 2025 | $118.2M | +9% |
| Q3 2025 | $110.4M | +6.2% |
| Q2 2025 | $114.6M | +3.4% |
| Q1 2025 | $114M | +6.3% |
| Q4 2024 | $108.5M | +8.4% |
FLXS's revenue has grown year over year for 12 quarters in a row: $114M last quarter, up 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6% | -2.1 points |
| Q2 2026 | 14% | +2 points |
| Q1 2026 | 7.1% | +12 points |
| Q4 2025 | 7.6% | -3.1 points |
| Q3 2025 | 8.1% | +2.3 points |
| Q2 2025 | 12% | +5.3 points |
| Q1 2025 | -4.4% | -7.2 points |
| Q4 2024 | 11% | +6.2 points |
FLXS has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over FLXS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
FLXS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.4M | -188% |
| Q2 2026 | $23.9M | +59% |
| Q1 2026 | $21.6M | +98% |
| Q4 2025 | -$735K | -113% |
| Q3 2025 | $2.8M | +40% |
| Q2 2025 | $15.1M | +112% |
| Q1 2025 | $10.9M | +85% |
| Q4 2024 | $5.8M | -66% |
FLXS has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
FLXS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.2x | Net Cash |
| Q3 2025 | -1.2x | Net Cash |
| Q3 2024 | -0.1x | Net Cash |
| Q2 2024 | 0.0x | Very low |
| Q1 2024 | 0.5x | Very low |
FLXS has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
FLXS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.4 | Neutral |
| Stochastic | 33.8 | Neutral |
FLXS's weekly RSI is 52 (neutral) and its Stochastic is 34 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
FLXS PE vs Consumer Cyclical Sector
| Metric | FLXS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 18x | 31% below |
| PE % | 43 | 47 | 4 pts below |
FLXS is trading at 13x earnings, a 31% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
FLXS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $81.5 | 7.8% below |
| 20 week MA | $78.7 | 4.5% below |
| 50 week MA | $61.4 | 22% above |
| 100 week MA | $50.9 | 48% above |
| 200 week MA | $40.1 | 87% above |
FLXS has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
FLXS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.5 | $34.8 | +70% |
| 2021 | $34.8 | $25.7 | -26% |
| 2022 | $25.7 | $15.8 | -38% |
| 2023 | $15.8 | $18.9 | +19% |
| 2024 | $18.9 | $55.4 | +194% |
| 2025 | $55.4 | $40.8 | -26% |
| 2026 YTD | $40.8 | $75.1 | +84% |
FLXS has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.